Aug 4, 2021 07:00AM

Jul 28, 2021 07:43PM

Jul 27, 2021 04:15PM

Jul 27, 2021 04:14PM

Jul 21, 2021 08:37PM

Jul 13, 2021 07:00AM

Jul 9, 2021 07:00AM Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th

Jul 8, 2021 06:00PM

Jul 6, 2021 07:00AM

Jun 28, 2021 08:08AM

Jun 28, 2021 08:06AM

Jun 28, 2021 08:03AM

Jun 25, 2021 07:00AM

Jun 24, 2021 07:00AM Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board

Jun 23, 2021 08:35AM

Jun 22, 2021 07:00AM

Jun 18, 2021 04:22PM

Jun 16, 2021 07:00AM

Jun 11, 2021 04:15PM

Jun 8, 2021 07:00AM

Jun 2, 2021 05:59PM Cybin to Present at the 2021 LD Micro Invitational XI on June 10, 2021

Jun 1, 2021 07:00AM

May 28, 2021 07:00AM

May 26, 2021 07:00AM

May 20, 2021 07:00AM

May 18, 2021 07:00AM

May 6, 2021 04:30PM

Apr 26, 2021 07:15AM Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Apr 21, 2021 07:15AM

Apr 19, 2021 07:15AM

Apr 13, 2021 07:15AM

Mar 30, 2021 07:15AM

Mar 22, 2021 07:15AM

Mar 17, 2021 07:15AM

Mar 9, 2021 09:15AM Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursua

Mar 8, 2021 06:00AM

Mar 3, 2021 06:00AM

322,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All